Fig3ACompareBestDesc

Figshare2021-02-21 更新2026-04-28 收录

炎症指数优化

药物疗效评估

数据链接：

https://figshare.com/articles/dataset/Fig3ACompareBestDesc/14071403 数据链接链接失效反馈

官方服务：

资源简介：

Data for Fig 3A comparing the best number of descriptors to include in the Inflammation Index. Plotting 'InfInd' by 'Treatment' split by 'No. Descriptors'

创建时间：

2021-02-21

Supplementary Material – ECZTRA 5 Manuscript

药物疗效评估

免疫反应

Supplementary Information to accompany and support the manuscript: Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults

Mendeley Data2024-03-27 更新210

DOM FIGURE S1 Supplementary data for studies in Figure 3.

药物疗效评估

代谢疾病模型

A,B. Body weights of the 1-wk study (Fig. 3A-D). C. Body weights for the 4-week and 8-week study (Fig. 3E-L). D. Liver gene expression of 1-wk treatment with PF-04991532. E-G. Plasma insulin of drug t

DataCite Commons2020-06-25 更新70

Changes in body weight in the different groups (*p < 0.05).

体重变化监测

药物疗效评估

D0: start of the treatment. D7: 8th day of treatment. D15: 16th day of treatment. D21: 22h day of treatment. D29: 30th day of treatment. Changes in body weight in the different groups (*p < 0.05).

NIAID Data Ecosystem30

Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials

肥胖治疗

药物疗效评估

As the pandemic of obesity presents an increasing serious health challenge worldwide, additional medical interventions, especially pharmacotherapy, should be addressed for the affected people. Liraglu

DataCite Commons2024-02-16 更新90

Second-line treatment of metastatic colorectal cancer with HR070803 in combination with 5-FU/LV and BP102

肿瘤临床试验

药物疗效评估

Interventions: experimental group:HR0708035, FU/LV and BP102 Primary outcome(s): Objective response rate Study Design: Single arm

NIAID Data Ecosystem40